Cite

Copy

Tap on and choose 'Add to Home Screen' to create a shortcut app

Tap on and choose 'Install/Install App' to create a shortcut app

Outcome of Therapies for Supratentorial Ependymomas in Children

This page was last updated on May 9th, 2017

Outcome After Surgery

Prognostic factors

  • Histological grade: Anaplastic tumors (WHO grade III) are more likely to occur in a supratentorial location. One study showed a 50% recurrence rate for anaplastic ependymomas despite gross total resection and radiation (19).
  • Age: Children younger than 3 years have poorer 5-year survival and progression-free survival rates compared to those who are older than 3 years (24). This may be due to incomplete surgical resections or a delay in the administration of radiation.
  • Extent of surgical resection: A complete resection infers a 5-year survival rate of 60–80% for ependymomas in general and a 70–80% disease-free survival rate at 48–120 months for patients with totally resected supratentorial ependymomas (4, 16).  Only 42–62% of patients experience a complete resection.  The 5-year survival rate is only 20–22% for incompletely resected ependymomas regardless of their locations.

Axial T1-weighted contrast MRI image showing recurrent anaplastic ependymoma, with multiple daughter nodules:

 

Outcome After Nonsurgical Treatments

Radiotherapy

  • No role for radiotherapy alone:  The current strategy is to irradiate after surgery (see above).  Radiotherapy should not be unduly delayed, preferably not later than 1 year after diagnosis.

Chemotherapy

  • No role for chemotherapy alone: Carboplatin and etoposide are frequently used because of CNS penetration.  The current strategy is to use chemotherapy to make second-stage resection more amenable to complete resection (18, 25).
  • Possible role as preoperative treatment: In several series a complete surgical resection of the tumor was achieved in 75% of patients who were pretreated with chemotherapy (17, 18).

Outcome After Multimodal Therapies

Surgery plus postoperative radiotherapy

  • 5-year survival rates of 40–88%: The overall survival rate for ependymomas, regardless of their location, is 40–88% with combined surgery and radiation as opposed to 17–38% for those patients managed with surgery alone (1, 21).
  • Neurological function: Common sequelae include abnormal gait, difficulties with fine motor function, and cognitive impairment (from radiotherapy), occurring in 35–55% of cases. 30% of patients require placement of a ventriculoperitoneal shunt (22).

Your donations keep us going

The ISPN Guide is free to use, but we rely on donations to fund our ongoing work and to maintain more than a thousand pages of information created to disseminate the most up-to-date knowledge in the field of paediatric neurosurgery.

By making a donation to The ISPN Guide you are also indirectly helping the many thousands of children around the world whose treatment depends on well-informed surgeons.

Please consider making a donation today.

Use the app

The ISPN Guide can be used as a standalone app, both on mobile devices and desktop computers. It’s quick and easy to use.

Fully featured

Free registration grants you full access to The Guide and host of featured designed to help further your own education.

Stay updated

The ISPN Guide continues to expand both in breadth and depth. Join our mailing list to stay up-to-date with our progress.